Please login to the form below
CDC
This page shows the latest CDC news and features for those working in and with pharma, biotech and healthcare.
CDC shows new BQ.1 and BQ 1.1 Omicron subvariants account for 44% of US COVID-19 cases
CDC. Those who have had COVID-19 before are still susceptible to infection, but vaccines are helping to protect against serious illness. ... However, the CDC reports that uptake of the new bivalent booster has been low since the organisation recommended
Latest news
-
Novavax’s COVID-19 vaccine candidate approved for emergency use by FDA as a booster
Following the FDA’s decision, the US Centers for Disease Control and Prevention (CDC) recommended use of the vaccine as a booster. ... According to CDC data, almost 50% of adults who received their primary series have yet to receive their first booster
-
Pfizer/BioNTech BA.4/BA.5 COVID-19 booster approved for emergency use by FDA in children five to 11 years
The doses will be shipped immediately, pending recommendation from the Centers for Disease Control and Prevention (CDC), the companies outlined in a statement. ... Anticipating this need, we manufactured millions of booster doses, which will be made
-
AstraZeneca/Sanofi’s Beyfortus receives CHMP recommendation for prevention of RSV disease in infants
Although most people recover within a week or two, the virus can be dangerous, especially for infants and older adults, according to the Centers for Disease Control and Prevention (CDC).
-
Locus Biosciences announces first patient treated in urinary tract infection trial
Antibiotic-resistant E coli has been identified by both the US Centers for Disease Control and Prevention (CDC) and World Health Organization (WHO) as an ‘urgent and serious’ public health threat
-
Pfizer and BioNTech granted FDA Emergency Use Authorisation for BA.4/BA.5 COVID-19 booster
to start subject to and after the Centers for Disease Control and Prevention (CDC) endorse a potential recommendation by the Advisory Committee on Immunization Practices (ACIP).
More from news
Approximately 8 fully matching, plus 103 partially matching documents found.
Latest Intelligence
-
Influenza – the risk to vulnerable populations
In the US, the Advisory Committee on Immunization Practices (ACIP), which is an advisory committee to the Centers for Disease Control and Prevention (CDC) on vaccine- preventable diseases, voted to preferentially
-
Healthcare communications – adapting to ‘the new normal’
WHO and CDC even started to compete with the media as primary sources cited by influencers.
-
The global antibiotic crisis: a 2020 perspective
A report from the CDC says the ‘approaching’ post-antibiotic era is already here. ... According to the 2019 CDC report, over 2.8 million US patients contracted a drug-resistant infection in 2017, and over 35, 000 died as a result.
-
How behavioural design is transforming the role and impact of life sciences in healthcare
II] Up to 40% of annual deaths from each of five leading US causes are preventable, Centers for Disease Control and Prevention (accessed via www.cdc.gov, 26 February 2018).
-
Advancing women in healthcare
Centers for Disease Control and Prevention (CDC) and overseeing a restructuring of the government agency’s multibillion dollar budget and 10, 000 employees.
More from intelligence
Approximately 0 fully matching, plus 9 partially matching documents found.
Latest appointments
-
Dr Engelbert Tjeenk Willink joins Allecra Therapeutics
by the US Center for Disease Control (CDC).
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
Diabetes management – should there be a 'one-size fit all' approach?
CDC. Just Diagnosed With Type 1 Diabetes.
-
LOOKING AHEAD: UNDERSTANDING THE NHS CUSTOMER’S PRIORITIES FOR 2022/23
to this, with the lynchpin being the roll-out of new Community Diagnostic Centres (CDCs). ... CDCs, for one, are likely to become important stakeholders and industry should check their remit and staffing locally, as they may well become the gatekeepers
-
WHITE PAPER: From bench to bedside in one year - how the race for a COVID-19 vaccine will change the future of drug development
CDC. https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different vaccines/viralvector.html. Published April 13, 2021. Accessed June 10, 2021.
-
5 ways that lockdowns and restrictions could be affecting our allergies
Accessed April 23, 2021. CDC, Published 2021.
-
Blog - Vaccine Hesitant? It’s About What You Know and Who You Trust
Consider the measles outbreak of 2019 in the US. In 2000, the Centers for Disease Control (CDC) deemed measles eradicated as an endemic disease in the US, but in 2019, an
More from PMHub
Approximately 0 fully matching, plus 11 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- Eli Lilly announces $450m investment in US manufacturing site
- Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
- Sandoz’s high concentration Hyrimoz formulation recommended for use in EU
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- GSK to submit drug application for new antibiotic to US FDA
- EU outlines measures to mitigate antibiotic shortage across Europe
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
